Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication

Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD—part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug’s purported benefits.

​Medical Xpress – latest medical and health news stories

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *